← Back to Search

Behavioral Intervention

DSMES+CHW (IDEAL) for Type 2 Diabetes (IDEAL Trial)

N/A
Waitlist Available
Led By Lu Hu, PhD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 12
Awards & highlights

IDEAL Trial Summary

This trial aims to study how effective a video-based Diabetes Self-Management Education and Support (DSMES) program, along with community health worker support, is in helping Chinese immigrants with Type 2 diabetes

Who is the study for?
This trial is for low-income Chinese immigrants in NYC with Type 2 diabetes. Participants should not have received the DSMES videos or CHW support before. They must be willing to receive text messages and engage with community resources if needed.Check my eligibility
What is being tested?
The study compares two groups: one receives weekly diabetes education videos via text and help from a community health worker for 24 weeks, while the other continues usual care and gets the videos after the study ends.See study design
What are the potential side effects?
Since this intervention involves educational materials and community support rather than medication, there are no direct medical side effects expected. However, participants may experience stress or time demands.

IDEAL Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Hemoglobin A1C (HbA1c) Test Scores
Secondary outcome measures
International Physical Activity Questionnaire (IPAQ) Short-Version Score
National Cancer Institute Dietary Screener Questionnaire Score
Stanford Self-Efficacy for Diabetes Scale Score
+2 more

IDEAL Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: DSMES+CHW (IDEAL)Experimental Treatment2 Interventions
Participants in this group will receive brief pre-recorded DSMES videos, which include both educational and Social Cognitive Theory-based behavioral content. Participants will receive 1 DSMES video via text message each week for a total of 24 weeks with each video lasting about 5 minutes in duration. In addition, they will also receive brief phone calls from CHWs every 2 weeks during the 24 weeks video program. During these calls, CHWs will assess whether participants need assistance on social determinants of health (SDOH) barriers. If needed, CHWs will link participants to available services within the community. CHWs will also provide assistance on navigating the complex health care systems and serve as an advocate for patients during doctor visits if needed.
Group II: Wait-list control group (CONTROL)Active Control1 Intervention
Participants in this group will continue to receive the standard of usual care for their T2D at their doctor's office during the course of our study.

Find a Location

Who is running the clinical trial?

Agency for Healthcare Research and Quality (AHRQ)FED
399 Previous Clinical Trials
6,822,078 Total Patients Enrolled
NYU Langone HealthLead Sponsor
1,368 Previous Clinical Trials
839,456 Total Patients Enrolled
Lu Hu, PhDPrincipal InvestigatorNYU School of Medicine
4 Previous Clinical Trials
580 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals aged 70 and above being included in the recruitment for this study?

"Prospective participants should be of an age greater than 18 years and less than 70 years to qualify for inclusion in this research."

Answered by AI

Are patients currently able to enroll in this ongoing clinical trial?

"According to information on clinicaltrials.gov, this particular trial is not currently recruiting participants. It was initially listed on 5/1/2024 and last revised on 3/13/2024. Despite this trial no longer accepting new participants, there are currently 1331 other studies actively enrolling patients at present."

Answered by AI

Which specific criteria must individuals meet in order to be eligible for participation in this research study?

"To be eligible for this research project, individuals must have a diagnosis of type 2 diabetes and fall within the age range of 18 to 70. The objective is to enroll approximately 270 participants in total."

Answered by AI
~180 spots leftby Oct 2027